SensiGen's Angel Round

SensiGen raised a round of funding on , . Investors include Delaware Crossing Investment Group.

SensiGen is a biotechnology company. They specialize creating tests to screen for diseases more efficiently and quickly. Their goal is to lower the overall costs of diagnosing serious diseases, usuall…

Articles about SensiGen's Angel Round: